Welchol (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1935696&contenttype=sentryarticle&channelID=26

Comments are closed.